1.Elevated plasma levels of vascular endothelial growth factor is associated with marked splenomegaly in chronic myeloid leukemia. Leuk Lymphoma,2005,46(12):1761-1764. 2.The investigation of mutation and single nucleotide polymorphism of receptor tyrosine kinases and downstream scaffold molecules in acute myeloid leukemia. Leuk Lymphoma,2006,47(12):2610-2616. 3.Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia. Leuk Res,2007,31:1383-1388. 4.The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia. Leuk Lymphoma,2007,48(9):1785-1792. 5.Interphase Fluorescence in situ Hybridization Detection of Cytogenetic Abnormalities in Chinese patients with B-cell Chronic Lymphocytic Leukemia. Int J Hematol,2007,85(5):430-436. 6.MicroRNA gene expression in malignant lymphoproliferative disorders. Chin Med J,2007,120(11):996-999. 7.Successful application of nonmyeloablative stem cell transplantation for paroxysmal nocturnal hemoglobinuria. Chin Med J,2007,120(22):2056-2058. 8.Supraclavicular lymph node tuberculosis presenting with immune thrombocytopenic purpura.Chin Med J,2007,120(19):1730-1731. 9.Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia. Leuk Res(2007),doi:10.1016/j.leukres.2007.10.009. 10.Outcome of treatment with Hyper-CVAD regimen in Chinese patients with acute lymphocytic leukemia. Leuk Res(2007),doi:10.1016/j.leukres.2007.10.019. 11.The investigation of JAK2 mutation in Chinese myeloproliferative diseases-identification of a novel C616Y point mutation in a PV patient. Int J Lab Hematol,2007,29:71-72. |